(Q41515973)

2 October 2017

1 reference

title

Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines (English)

1 reference

2 October 2017

Fromenty B

1

1 reference

PubMed ID

9204409

2 October 2017

Pessayre D

series ordinal

2

1 reference

2 October 2017

1 January 1997

1 reference

2 October 2017

Journal of Hepatology

1 reference

2 October 2017

26 Suppl 2

1 reference

2 October 2017

43-53

1 reference

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980496-5

7 January 2021

Mitochondrial encephalomyopathies: clinical and molecular analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980496-5

7 January 2021

Regulation of palmitoylcarnitine oxidation in isolated rat liver mitochondria. Role of the redox state of NAD(H).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980496-5

7 January 2021

Ammonium inhibition of fatty acid oxidation in rat liver mitochondria. A possible cause of fatty liver in Reye's syndrome and urea cycle defects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980496-5

7 January 2021

Decreased mitochondrial oxidation of fatty acids in pregnant mice: possible relevance to development of acute fatty liver of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980496-5

7 January 2021

Reye's syndrome: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980496-5

7 January 2021

10.1016/S0168-8278(97)80496-5

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9204409